Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

被引:293
作者
Chen, YNP
Sharma, SK
Ramsey, TM
Jiang, L
Martin, MS
Baker, K
Adams, PD
Bair, KW
Kaelin, WG
机构
[1] Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA
[2] Nova Pharmaceut Corp, Novartis Inst Biomed Res, Summit, NJ 07901 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.96.8.4325
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent studies identified a short peptide motif that serves as a docking site for cyclin/cyclin-dependent kinase (cdk) 2 complexes. Peptides containing this motif block the phosphorylation of substrates by cyclin A/cdk2 or cyclin E/cdk2. Here we report that cell membrane-permeable forms of such peptides preferentially induced transformed cells to undergo apoptosis relative to nontransformed cells. Deregulation of E2F family transcription factors is a common event during transformation and was sufficient to sensitize cells to the cyclin/cdk2 inhibitory peptides, These results suggest that deregulation of E2F and inhibition of cdk2 are synthetically lethal and provide a rationale for the development of cdk2 antagonists as antineoplastic agents.
引用
收藏
页码:4325 / 4329
页数:5
相关论文
共 29 条
[1]  
Adams PD, 1996, MOL CELL BIOL, V16, P6623
[2]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[3]  
Chen JJ, 1996, MOL CELL BIOL, V16, P4673
[4]   DIFFERENTIAL REGULATION OF E2F TRANSACTIVATION BY CYCLIN CDK2 COMPLEXES [J].
DYNLACHT, BD ;
FLORES, O ;
LEES, JA ;
HARLOW, E .
GENES & DEVELOPMENT, 1994, 8 (15) :1772-1786
[5]   Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16(CDKN2/INK4A) [J].
Fahraeus, R ;
Paramio, JM ;
Ball, KL ;
Lain, S ;
Lane, DP .
CURRENT BIOLOGY, 1996, 6 (01) :84-91
[6]   TAT-MEDIATED DELIVERY OF HETEROLOGOUS PROTEINS INTO CELLS [J].
FAWELL, S ;
SEERY, J ;
DAIKH, Y ;
MOORE, C ;
CHEN, LL ;
PEPINSKY, B ;
BARSOUM, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :664-668
[7]   Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo [J].
Fueyo, J ;
Gomez-Manzano, C ;
Yung, WKA ;
Liu, TJ ;
Alemany, R ;
McDonnell, TJ ;
Shi, X ;
Rao, JS ;
Levin, VA ;
Kyritsis, AP .
NATURE MEDICINE, 1998, 4 (06) :685-690
[8]   MULTIPLE DNA ELEMENTS ARE REQUIRED FOR THE GROWTH-REGULATION OF THE MOUSE E2F1 PROMOTER [J].
HSIAO, KM ;
MCMAHON, SL ;
FARNHAM, PJ .
GENES & DEVELOPMENT, 1994, 8 (13) :1526-1537
[9]   E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction [J].
Hsieh, JK ;
Fredersdorf, S ;
Kouzarides, T ;
Martin, K ;
Lu, X .
GENES & DEVELOPMENT, 1997, 11 (14) :1840-1852
[10]   AUTOREGULATORY CONTROL OF E2F1 EXPRESSION IN RESPONSE TO POSITIVE AND NEGATIVE REGULATORS OF CELL-CYCLE PROGRESSION [J].
JOHNSON, DG ;
OHTANI, K ;
NEVINS, JR .
GENES & DEVELOPMENT, 1994, 8 (13) :1514-1525